Israel Active

Israel’s MobileODT demonstrated its life-saving smartphone technology to detect cervical cancer at the Innovation Showcase at this year’s AIPAC Conference.  Launched only last May it has been used 6000 times in 20 countries.

Israel’s Rosetta Genomics has announced that its RosettaGX Reveal diagnostic test for thyroid cancer is now approved for use in all 50 US states.

Israel’s BioLight Life Sciences has completed a successful U.S. clinical study designed to assess the effectiveness of its TeaRx multi-assay test in evaluating tears’ components of patients suffering from dry eye syndrome (DES) as well as those of healthy subjects.

Israel’s Hospitech Respiration has received US FDA clearance for its AnapnoGuard 100 intubation system.  AnapnoGuard is already CE2 cleared.  More than 100 million patients annually require manual ventilation - the largest reason for admission into intensive care.

Currently it is not possible to freeze organs in order to preserve them for later transplant. Now researchers at the Hebrew University of Jerusalem have studied ice-binding “antifreeze proteins” that protect frozen cells from expansion damage when they thaw out.

Israel’s Amir Goldenthal began his PhD when he was 16 and just one year into his first degree. Now 19, his doctoral dissertation involves breakthroughs in the understanding of neurological diseases such as epilepsy, Alzheimer's and Parkinson's. Amir won a prize at the Nobel Laureates Conference in Japan for best research paper.

Here is a video to demonstrate the power of the portable ultrasound device developed in the laboratory of Israel Technion’s Professor Yonina Eldar.

US giant Merck has signed a new framework agreement with Israel’s Weizmann Institute to research new solutions in the area of biotechnology and cancer research. Merck has more than 300 employees at four sites throughout Israel.

Researchers at Tel Aviv University have discovered evidence of colon cancer in the mummified remains of an 18th century Hungarian corpse. The mutation of the Adenomatous polyposis coli (APC) gene is the earliest recorded case of colorectal cancer.

Israeli startup Intensix is trialing an Intensive Care Unit patient monitoring system at Tel Aviv Sourasky (Ichilov) hospital. Using data collected from 8,000 patients over the past 8 years, the system gives an early warning of impending sepsis and organ failure that kills 30% of ICU patients.